Live Webinar on Dec 4! Cut Through the AI Noise: A Framework for Canadian Clinicians. Register now
This hub features a concise series of microlearnings on emerging non-hormonal therapies for vasomotor symptoms (VMS). Content moves from core physiology to newly authorized treatment options in Canada, with a focus on mechanisms of action, clinical evidence, patient selection, monitoring, and case-based application. Together, these modules support practical, evidence-informed management of VMS for patients who are unable or prefer not to use hormone therapy.